The previous post, regarding the DEA’s suspension of McKesson Corporation’s sales of controlled substances from distribution in Florida, was found to be confusing. This suspension will impact one distribution center in Florida and impacts only the handling of hydromorphone. The Florida Department of Health and Division of Medical Quality Assurance apologizes for any confusion that may have resulted from that message. For specific details about McKesson’s agreement with the DEA, please contact the DEA. For questions about the potential impact of the sanctions in Florida, please contact the DOH’s Medical Quality Assurance.
More Latest News
August 3, 2021
Access current information about the NLC, including a current map of states which are part of the Compact Continue reading
August 2, 2021
The agenda for the upcoming August 5-6, 2021 Board Meeting has been published. You may locate the agenda by visiting https://floridasnursing.gov/meeting-information/upcoming-meetings/.